Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bausch initiates stalking horse bid process for Synergy Pharma; deal completed

Executive Summary

Concurrent with filing for Chapter 11, Synergy Pharmaceuticals Inc. signed a definitive agreement under a court-supervised stalking horse bid process to sell substantially all its assets, including all rights to Trulance (plecanatide), to Bausch Health Companies Inc. for $200mm in cash

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies